Welcome to our dedicated page for Origin Materials SEC filings (Ticker: ORGNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Turning sawdust into high-performance polymers is impressive—decoding the disclosures behind that chemistry is another matter. If you have ever tried to sift through a dense 10-K to confirm carbon-intensity metrics or parse construction updates on Origin Materials’ Louisiana plant, you know the struggle. Origin Materials SEC filings explained simply is what most investors want, but EDGAR alone does not deliver.
Stock Titan bridges that gap with AI-powered summaries, trend charts and real-time alerts. Need the Origin Materials quarterly earnings report 10-Q filing to see feedstock cost swings? We highlight the numbers and compare them to last quarter. Want the Origin Materials annual report 10-K simplified so you can grasp revenue from licensing? Our natural-language recap surfaces it in seconds. From Origin Materials proxy statement executive compensation details to cap-table shifts after warrants, everything is tagged and searchable. We even break down Origin Materials 8-K material events explained—plant delays, new offtake agreements, or carbon-credit sales—minutes after they hit EDGAR. It’s all part of understanding Origin Materials SEC documents with AI in one streamlined dashboard, complete with Origin Materials earnings report filing analysis.
Monitoring executive moves is just as easy: follow Origin Materials insider trading Form 4 transactions and get Origin Materials Form 4 insider transactions real-time notifications when warrants convert or options vest. Curious about larger patterns? Our heat-map of Origin Materials executive stock transactions Form 4 shows buying vs. selling over time. With comprehensive coverage of every filing type and AI that points you to what matters, Stock Titan lets you focus on decisions, not document hunting.
Form 4 overview: Director Laura Berner of Bolt Biotherapeutics (BOLT) reported a single equity-based transaction dated May 27 2025. She received a non-qualified stock option for 1,100 common shares at an exercise price of $6.40 per share. All figures give effect to the 1-for-20 reverse stock split that the company executed on June 6 2025.
Key terms of the grant:
- Vesting: Options vest on the earlier of May 27 2026 or the day immediately prior to the next annual meeting, subject to continued service.
- Change-in-control: The award vests in full upon a change-in-control event.
- Expiration: May 26 2035 (10-year life).
No shares were purchased or sold; the filing reflects compensation-related option issuance. Post-grant, Berner beneficially owns 1,100 derivative securities and no disclosed non-derivative common shares.
Corporate context: The recent reverse split consolidated each 20 common shares into one, reducing the share count and proportionally increasing exercise prices. Prior to the split, the grant was for 22,000 shares at $0.32 per share. The filing provides no additional financial or operational data.
AT&T Inc. (T) – Form 4 insider filing: Director Cindy B. Taylor reported an automatic, in-plan acquisition of 6,219.765 deferred stock units (DSUs) on 06/30/2025 under the company’s Non-Employee Director Stock and Deferral Plan. Each DSU represents the economic value of one common share and is settled in cash after the director leaves the board. The reference price recorded for the underlying common stock was $28.94.
Following the transaction, Taylor’s direct equity holdings remain at 5,718 common shares and 320 Series C depositary shares, while her indirect derivative position increases to 196,964.0096 DSUs held through the benefit plan. No shares were sold or disposed of, and there were no option exercises or other derivative conversions disclosed.
The filing indicates continued alignment between the director and shareholder interests but does not represent a material change to AT&T’s overall share structure or insiders’ cumulative ownership.
AT&T Inc. (T) – Form 4 insider filing: Director Cindy B. Taylor reported an automatic, in-plan acquisition of 6,219.765 deferred stock units (DSUs) on 06/30/2025 under the company’s Non-Employee Director Stock and Deferral Plan. Each DSU represents the economic value of one common share and is settled in cash after the director leaves the board. The reference price recorded for the underlying common stock was $28.94.
Following the transaction, Taylor’s direct equity holdings remain at 5,718 common shares and 320 Series C depositary shares, while her indirect derivative position increases to 196,964.0096 DSUs held through the benefit plan. No shares were sold or disposed of, and there were no option exercises or other derivative conversions disclosed.
The filing indicates continued alignment between the director and shareholder interests but does not represent a material change to AT&T’s overall share structure or insiders’ cumulative ownership.
FAQ
What is the current stock price of Origin Materials (ORGNW)?
What is the core business of Origin Materials Inc?
How does Origin Materials achieve a carbon-negative process?
What industries benefit from Origin Materials' products?
How does Origin Materials differentiate itself from traditional materials providers?
What role does research and development play at Origin Materials?
How is the technology of Origin Materials integrated into industrial processes?
What is meant by the company’s focus on circular economy practices?
How does Origin Materials ensure sustainability in its operations?
